Results 131 to 140 of about 10,864 (208)

[Characteristics of patients with systemic sclerosis who develop interstitial lung disease]. [PDF]

Rev Med Inst Mex Seguro Soc, 2023
Fajardo-Hermosillo LD, Ocampo-Torres MC, Rodríguez-Silverio J.   +2 more
europepmc   +1 more source

[Pneumocystis pneumonia in rheumatoid arthritis treated with biologics: A case report]. [PDF]

Open Respir Arch, 2021
Méndez Salazar F, Pereiro T, Elguezabal E, Domínguez Pazos SJ, Vidal García I, Montero Martínez C.   +5 more
europepmc   +1 more source

Neumatosis intestinal secundaria a tratamiento inmunosupresor

Anales de Pediatría
Begoña de Miguel Lavisier, Miguel Ángel Molina Gutiérrez, Yasmina Mozo del Castillo, Eduardo Alonso Gamarra   +3 more
openaire   +1 more source

Síndrome de los anticuerpos antifosfolípido (y II): Estrategia terapéutica [PDF]

, 1994
Pallarés Ferreras, Lucio, Payeras Cifre, Antoni, Usandizaga Calparsoro, Manuel   +2 more
core  

Cruising the transition: Challenges and opportunities when caring for immunity inborn error patients [PDF]

Biomedica
Zea-Vera AF, Castaño-Jaramillo LM.
europepmc   +1 more source

Nuevos agentes inmunosupresores (drogas y anticuerpos monoclonales)

Medwave, 2002
openaire   +1 more source

Síndrome Nefrótico Idiopático IV Parte Inmunosupresores en el Síndrome Nefrótico [PDF]

Revista chilena de pediatría, 1974
RODRIGUEZ S, E, PUGA C, F, ROSENBERG, HELMAR   +2 more
openaire   +4 more sources

[Current Status of Passive Immunization Against COVID in Respiratory Patients]. [PDF]

Open Respir Arch
Mora Cuesta VM, Solís Gómez B, Pérez Rojo R.   +2 more
europepmc   +1 more source

Inmunosupresores y alteraciones de los lípidos

Nefrología, 2014
openaire   +1 more source

[Benefits of early use of high-flow-nasal-cannula (HFNC) in patients with COVID-19 associated pneumonia]. [PDF]

Med Clin (Barc), 2022
García-Pereña L, Ramos Sesma V, Tornero Divieso ML, Lluna Carrascosa A, Velasco Fuentes S, Parra-Ruiz J.   +5 more
europepmc   +1 more source